SARS-CoV-S
Full Name
                    SARS-CoV spike protein
                Function
                    Spike glycoprotein
May down-regulate host tetherin (BST2) by lysosomal degradation, thereby counteracting its antiviral activity.
Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection (By similarity).
Binding to human ACE2 and CLEC4M/DC-SIGNR receptors and internalization of the virus into the endosomes of the host cell induces conformational changes in the S glycoprotein. Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membrane fusion within endosomes.
Spike protein S2
Mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.
Spike protein S2'
Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.
                May down-regulate host tetherin (BST2) by lysosomal degradation, thereby counteracting its antiviral activity.
Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection (By similarity).
Binding to human ACE2 and CLEC4M/DC-SIGNR receptors and internalization of the virus into the endosomes of the host cell induces conformational changes in the S glycoprotein. Proteolysis by cathepsin CTSL may unmask the fusion peptide of S2 and activate membrane fusion within endosomes.
Spike protein S2
Mediates fusion of the virion and cellular membranes by acting as a class I viral fusion protein. Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes.
Spike protein S2'
Acts as a viral fusion peptide which is unmasked following S2 cleavage occurring upon virus endocytosis.
Biological Process
                    Biological Process endocytosis involved in viral entry into host cellIEA:UniProtKB-UniRule
Biological Process fusion of virus membrane with host endosome membraneIEA:UniProtKB-UniRule
Biological Process fusion of virus membrane with host plasma membraneIEA:UniProtKB-UniRule
Biological Process membrane fusion1 PublicationIC:ComplexPortal
Biological Process positive regulation of viral entry into host cell1 PublicationIC:ComplexPortal
Biological Process receptor-mediated endocytosis of virus by host cellIC:ComplexPortal
Biological Process receptor-mediated virion attachment to host cellManual Assertion Based On ExperimentIDA:BHF-UCL
Biological Process suppression by virus of host tetherin activityIEA:UniProtKB-KW
Biological Process suppression by virus of host type I interferon-mediated signaling pathwayIEA:UniProtKB-KW
Biological Process viral entry into host cellIDA:ComplexPortal
                Biological Process fusion of virus membrane with host endosome membraneIEA:UniProtKB-UniRule
Biological Process fusion of virus membrane with host plasma membraneIEA:UniProtKB-UniRule
Biological Process membrane fusion1 PublicationIC:ComplexPortal
Biological Process positive regulation of viral entry into host cell1 PublicationIC:ComplexPortal
Biological Process receptor-mediated endocytosis of virus by host cellIC:ComplexPortal
Biological Process receptor-mediated virion attachment to host cellManual Assertion Based On ExperimentIDA:BHF-UCL
Biological Process suppression by virus of host tetherin activityIEA:UniProtKB-KW
Biological Process suppression by virus of host type I interferon-mediated signaling pathwayIEA:UniProtKB-KW
Biological Process viral entry into host cellIDA:ComplexPortal
Cellular Location
                    Virion membrane
Host endoplasmic reticulum-Golgi intermediate compartment membrane
Host cell membrane
Accumulates in the endoplasmic reticulum-Golgi intermediate compartment, where it participates in virus particle assembly. Colocalizes with S in the host endoplasmic reticulum-Golgi intermediate compartment (PubMed:20861307).
Some S oligomers are transported to the host plasma membrane, where they may mediate cell-cell fusion.
                Host endoplasmic reticulum-Golgi intermediate compartment membrane
Host cell membrane
Accumulates in the endoplasmic reticulum-Golgi intermediate compartment, where it participates in virus particle assembly. Colocalizes with S in the host endoplasmic reticulum-Golgi intermediate compartment (PubMed:20861307).
Some S oligomers are transported to the host plasma membrane, where they may mediate cell-cell fusion.
Topology
                    Extracellular: 14-1195
Helical: 1196-1216
Cytoplasmic: 1217-1255
                Helical: 1196-1216
Cytoplasmic: 1217-1255
PTM
                    The cytoplasmic Cys-rich domain is palmitoylated. Spike glycoprotein is digested by cathepsin CTSL within endosomes.1 Publication
Specific enzymatic cleavages in vivo yield mature proteins. The precursor is processed into S1 and S2 by host cell furin or another cellular protease to yield the mature S1 and S2 proteins. Additionally, a second cleavage leads to the release of a fusion peptide after viral attachment to host cell receptor.
The cytoplasmic Cys-rich domain is palmitoylated. Spike glycoprotein is digested within host endosomes.
                Specific enzymatic cleavages in vivo yield mature proteins. The precursor is processed into S1 and S2 by host cell furin or another cellular protease to yield the mature S1 and S2 proteins. Additionally, a second cleavage leads to the release of a fusion peptide after viral attachment to host cell receptor.
The cytoplasmic Cys-rich domain is palmitoylated. Spike glycoprotein is digested within host endosomes.
                            View more
                        
   
                    Anti-SARS-CoV-S antibodies
 + Filters
		 Loading...
Loading...
        Target: SARS-CoV-S
                
                Host: Mouse
                
                Antibody Isotype: IgG2
                
                Specificity: SARS Coronavirus
                
                Clone: CB2
                
                Application*: ELISA, WB
                
            Target: SARS-CoV-S
                
                Host: Mouse
                
                Antibody Isotype: IgG1
                
                Specificity: SARS Coronavirus
                
                Clone: CB1
                
                Application*: ELISA, WB
                
            More Infomation
Hot products 
    - 
            Mouse Anti-CTCF Recombinant Antibody (CBFYC-2371) (CBMAB-C2443-FY)  
- 
            Mouse Anti-CD46 Recombinant Antibody (CBFYC-0076) (CBMAB-C0085-FY)  
- 
            Mouse Anti-COL12A1 Recombinant Antibody (CBYY-C3117) (CBMAB-C4560-YY)  
- 
            Mouse Anti-CAPZB Recombinant Antibody (CBYY-C0944) (CBMAB-C2381-YY)  
- 
            Rat Anti-CD34 Recombinant Antibody (MEC 14.7) (CBMAB-C10196-LY)  
- 
            Mouse Anti-ATG5 Recombinant Antibody (9H197) (CBMAB-A3945-YC)  
- 
            Mouse Anti-BHMT Recombinant Antibody (CBYY-0547) (CBMAB-0550-YY)  
- 
            Rat Anti-C5AR1 Recombinant Antibody (8D6) (CBMAB-C9139-LY)  
- 
            Mouse Anti-CD24 Recombinant Antibody (SN3) (CBMAB-C1037-CQ)  
- 
            Mouse Anti-ARID3A Antibody (A4) (CBMAB-0128-YC)  
- 
            Mouse Anti-CCND2 Recombinant Antibody (DCS-3) (CBMAB-G1318-LY)  
- 
            Mouse Anti-BAD (Phospho-Ser136) Recombinant Antibody (CBYY-0138) (CBMAB-0139-YY)  
- 
            Rabbit Anti-ADRA1A Recombinant Antibody (V2-12532) (CBMAB-1022-CN)  
- 
            Mouse Anti-CIITA Recombinant Antibody (CBLC160-LY) (CBMAB-C10987-LY)  
- 
            Mouse Anti-DLG1 Monolconal Antibody (4F3) (CBMAB-0225-CN)  
- 
            Rat Anti-CD300A Recombinant Antibody (172224) (CBMAB-C0423-LY)  
- 
            Mouse Anti-ANXA7 Recombinant Antibody (A-1) (CBMAB-A2941-YC)  
- 
            Mouse Anti-DLL4 Recombinant Antibody (D1090) (CBMAB-D1090-YC)  
- 
            Mouse Anti-BCL6 Recombinant Antibody (CBYY-0442) (CBMAB-0445-YY)  
- 
            Rabbit Anti-Acetyl-Histone H4 (Lys16) Recombinant Antibody (V2-623415) (CBMAB-CP1021-LY)  
For Research Use Only. Not For Clinical Use.
                    (P): Predicted
* Abbreviations 
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
 
                Online Inquiry
                
    
           
        
 Compare
Compare 
        


